SEC Form 4 · accession 0001127602-16-048854
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cox
Officer — EVP Pharmaceutical Oper & Tech
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 1, 2016 | A | 8,444 | $0.00 | A | 39,045 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 84.8551 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2016.